References of "Delanaye, Pierre"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailOutcome of the living kidney donor
DELANAYE, Pierre ULg; WEEKERS, Laurent ULg; DUBOIS, Bernard ULg et al

in Nephrology Dialysis Transplantation (2012), 27(1), 41-50

Renal transplantation from living kidney donors is still relatively marginal in most of the European countries. However, this source of kidney grafts may help to overcome in part the organ donor shortage ... [more ▼]

Renal transplantation from living kidney donors is still relatively marginal in most of the European countries. However, this source of kidney grafts may help to overcome in part the organ donor shortage of cadaveric donors. The living donor strategy implies correct and objective information about donation risks and completely free acceptance of the living candidate of the donation. In this paper, we reviewed the consequences of kidney donation on the living donor health, considering very short term (linked to the surgery), short term (effect of nephrectomy on glomerular filtration rate) and long term (risk of mortality, chronic kidney disease, proteinuria and hypertension) consequences of kidney donation. [less ▲]

Detailed reference viewed: 39 (8 ULg)
Peer Reviewed
See detailCKD-EPI GFR estimating equations in kidney transplantation: which added value for the new cystatin C based equations?
Masson, I; Maillard, N; Kamar, K et al

Poster (2012)

Detailed reference viewed: 6 (0 ULg)
Peer Reviewed
See detailCreatinine and/or cystatin C-based GFR estimation in HIV-infected patients
Gagneux-Brunon, A; DELANAYE, Pierre ULg; Delavenne, X et al

Poster (2012)

Detailed reference viewed: 3 (0 ULg)
Peer Reviewed
See detailTwo novel equations to estimate kidney function in persons aged 70 years or older
Schaeffner, ES; Ebert, N; DELANAYE, Pierre ULg et al

Poster (2012)

Detailed reference viewed: 3 (0 ULg)
Peer Reviewed
See detailPerformance, limitations and utility of cystatin C as an endogenous GFR marker in renal transplantation
Masson, I; Maillard, N; Tack, I et al

Poster (2012)

Detailed reference viewed: 1 (0 ULg)
See detailEstimating GFR in 2012: the creatinine-based equations
DELANAYE, Pierre ULg

Conference (2012)

Detailed reference viewed: 6 (0 ULg)
Full Text
Peer Reviewed
See detailNGAL biomarqueur de lésion rénale
Gagneux-Brunon, Amandine; DELANAYE, Pierre ULg; LEGRAND, Delphine ULg et al

in Néphrologie & Thérapeutique (2012), 8(7), 508-515

Le diagnostic precoce de l’insufissance renale aigue (IRA) est necessaire et devrait se faire au stade de lesion renale avant meme la degradation du debit de filtration glomerulaire. Plusieurs ... [more ▼]

Le diagnostic precoce de l’insufissance renale aigue (IRA) est necessaire et devrait se faire au stade de lesion renale avant meme la degradation du debit de filtration glomerulaire. Plusieurs biomarqueurs d’atteinte renale aigue sont actuellement a l’etude. Parmi ceux-ci, le Neutrophil Gelatinase Associated Lipocalin (NGAL) semble l’un des plus prometteurs et fait l’objet de nombreuses publications. La performance diagnostique de NGAL, dose dans le plasma ou les urines, pour le depistage de l’IRA depend de nombreux facteurs. Bien que les donnees experimentales recentes soient en faveur de l’utilisation preferentielle du dosage urinaire de NGAL, les donnees cliniques issues de nombreuses etudes ne permettent pas de trancher formellement sur la superiorite du dosage urinaire par rapport au dosage plasmatique pour le depistage des atteintes renales aigues. Il n’en reste pas moins que sur le plan analytique, les techniques de dosage du NGAL urinaire sont actuellement plus fiables que celles du dosage plasmatique. La performance diagnostique de NGAL dans un contexte d’IRA est maximale en chirurgie cardiaque pediatrique. Les resultats, chez l’adulte en postoperatoire de chirurgie cardiaque et dans d’autres situations (reanimation, urgences, transplantation), sont moins convaincants. Par ailleurs, il n’est actuellement pas possible d’extrapoler des etudes cliniques une valeur seuil discriminante unique de NGAL, aussi bien dans les urines que dans le plasma. D’autres etudes sont necessaires pour valider definitivement NGAL comme biomarqueur de l’atteinte renale aigue et en preciser les conditions d’utilisation en pratique clinique. [less ▲]

Detailed reference viewed: 88 (11 ULg)
Full Text
Peer Reviewed
See detailTwo novel equations to estimate kidney function in persons aged 70 years or older
Schaeffner, Elke; Ebert, Natalie; DELANAYE, Pierre ULg et al

in Annals of Internal Medicine (2012), 157(7), 471-481

Detailed reference viewed: 129 (0 ULg)
Full Text
See detailLe médicament du mois : Fébuxostat (Adenuric®)
DELANAYE, Pierre ULg; BOUQUEGNEAU, Antoine ULg; DUBOIS, Bernard ULg et al

in Revue Médicale de Liège (2012), 67(4), 202-209

Detailed reference viewed: 53 (1 ULg)
See detailCreatinine: Production, Physiology and Diagnostic Use in Kidney Diseases
DELANAYE, Pierre ULg; Vidal-Petiot, Emmanuelle; Flamant, Martin

in Perkins (Ed.) Creatinine: Production, Diagnostic Uses and role in Renal Disease (2012)

Detailed reference viewed: 50 (0 ULg)
Peer Reviewed
See detailHow measuring glomerular filtration rate? Comparison of reference methods
DELANAYE, Pierre ULg

in Sahay, Manisha (Ed.) Basic Nephrology and Acute Kidney Injury (2012)

Detailed reference viewed: 34 (0 ULg)
See detailNephrology and Clinical Chemistry: the essential link
DELANAYE, Pierre ULg

Book published by Bentham (2012)

Detailed reference viewed: 32 (0 ULg)
Full Text
Peer Reviewed
See detailCystatin C in HIV-infected patients: promising but not yet ready for prime time.
Gagneux-Brunon, Amandine; Mariat, Christophe; DELANAYE, Pierre ULg

in Nephrology Dialysis Transplantation (2012), 27(4), 1305-1313

Detailed reference viewed: 21 (0 ULg)